Previous 10 | Next 10 |
2024-04-04 17:03:51 ET DENVER, Colo., Apr 04, 2024 ( 247marketnews.com )- MoBot, the 24/7MN Momentum Bot, covered HWH International Inc. (NASDAQ: HWH ), Tevogen Bio Holdings Inc. (NASDAQ: TVGN), Candel Therapeutics, Inc. (NASDAQ: CADL ), and TC BioPharm (NASDAQ: TCBP ). ...
A look at the top 10 most actives in the United States Nikola Corporation (NKLA) rose 6.5% to $0.95 on volume of 182,734,103 shares WiSA Technologies Inc. (WISA) fell 3.3% to $0.0235 on volume of 160,634,740 shares PROSHARES TRUST (SQQQ) rose 4.7% to $11.12 on volume of 151,373,755 shares...
2024-04-04 13:06:43 ET More on Mid-day movers & stocks. Seeking Alpha’s Quant Rating on Barinthus Biotherapeutics Historical earnings data for Barinthus Biotherapeutics Financial information for Barinthus Biotherapeutics Seeking Alpha’s Quan...
2024-04-04 11:35:45 ET DENVER, Colo., Apr 04, 2024 ( 247marketnews.com )- Gorilla Technology Group (NASDAQ: GRRR ), Sportsman’s Warehouse Holdings, Inc. (NASDAQ: SPWH ), Candel Therapeutics, Inc. (NASDAQ: CADL ), Brera Holding (NASDAQ: ...
A look at the top 10 most actives in the United States WiSA Technologies Inc. (WISA) rose 0.8% to $0.0245 on volume of 49,663,616 shares TC BioPharm (Holdings) plc (TCBP) rose 134.2% to $3.045 on volume of 39,956,892 shares Nikola Corporation (NKLA) rose 8.1% to $0.963899 on volume of 31,...
2024-04-04 08:36:36 ET More on Candel Therapeutics Krystal Biotech, Candel, Edgewise gain after FDA fast track tags Seeking Alpha’s Quant Rating on Candel Therapeutics Historical earnings data for Candel Therapeutics Financial information for Candel Th...
2024-04-04 08:24:59 ET DENVER, Colo., Apr 04, 2024 ( 247marketnews.com )- Candel Therapeutics, Inc. (NASDAQ: CADL ) reported updated interim survival data from the ongoing randomized phase 2 clinical trial of CAN-2409 plus valacyclovir (prodrug), together with standard of care (SoC)...
Updated positive interim data showed notable improvements in estimated median overall survival of 28.8 months after experimental treatment with CAN-2409 versus only 12.5 months in control group in borderline resectable pancreatic ductal adenorcarcinoma (PDAC) At 24 months, survival rate...
The first cohort of patients were treated with multiple injections of CAN-3110 in the ongoing phase 1b clinical trial. The serial procedures were well tolerated without observed dose-limiting toxicity. A second cohort is being planned for enrollment in the ongoing phase 1b cli...
2024-03-28 09:00:07 ET More on Candel Therapeutics Krystal Biotech, Candel, Edgewise gain after FDA fast track tags Seeking Alpha’s Quant Rating on Candel Therapeutics Historical earnings data for Candel Therapeutics Financial information for Candel Th...
News, Short Squeeze, Breakout and More Instantly...
Candel Therapeutics Inc. Company Name:
CADL Stock Symbol:
NASDAQ Market:
Candel Therapeutics Inc. Website:
2024-06-27 01:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NEEDHAM, Mass., June 18, 2024 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL ), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced that Paul Pete...
2024-06-17 03:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...